MARK STLAWRENCE: Open Payments
NPI 1962446377 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,219 in 104 payments from 31 companies in 2025. Trend: 2023 $1,911 · 2024 $2,028 · 2025 $2,219
Food & beverage: $2,219
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $289 |
| Novo Nordisk Inc | 11 | $190 |
| Lilly USA, LLC | 3 | $163 |
| GlaxoSmithKline, LLC. | 7 | $149 |
| AstraZeneca Pharmaceuticals LP | 8 | $136 |
| Otsuka America Pharmaceutical, Inc. | 13 | $135 |
| Radius Health, Inc. | 4 | $117 |
| PFIZER INC. | 4 | $103 |
| ABBVIE INC. | 4 | $97 |
| Exact Sciences Corporation | 4 | $97 |
Products named: CAPLYTA, REXULTI, ZEPBOUND, TRELEGY ELLIPTA, TZIELD, Arikayce, NURTEC ODT, FARXIGA.
Industry payments across FL — which companies pay providers there.
